CellSource Co., Ltd. engages in regenerative medicine related business. Its business includes fat, blood-derived tissue and cell processing service. It also offers regenerative medicine legal support service, sale of medical device, cosmetics and facial products. It operates through the Regenerative Medicine-related and Consumer business segments. The Regenerative Medicine-related segment handles stem cell processing contract service, blood derived processing contract service and consulting service. It also sells equipment necessary for medical institutions to collect fat from patients. The Consumer segment mainly manufactures and sells cosmetics for the general consumer, such as beauty liquids, creams, facial cleansing gels, and own cosmetic brand SIGNALIFT. The company was founded on November 30, 2015 and is headquartered in Tokyo, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company